Hypermethylation of TIG1 Promoter in Intracranial Primitive Neuroectodermal Tumors

CHANG Qing,NG Ho-keung

DOI: https://doi.org/10.3969/j.issn.1001-7399.2006.04.021

2006-01-01

Abstract:Purpose To detect the methylation status of TIG1 promoter in intracranial primitive neuroectodermal tumor (PNET). Methods 25 cases of primary medulloblastomas (MBs),9 primary supratentorial intracranial primitive neuroectodermal tumor(SPNETs)and 7 PNET cell lines were examined by methylation specific PCR(MSP)method. Expression of TIG1 was identified in PNET cells by RT-PCR. Six cell lines were treated by the demethylation reagent, 5-aza-2′-deoxycytidine. The correlation between TIG1 promoter hypermethylation and its transcriptional status was explored. Results Aberrant promoter methylation of TIG1 in MBs and SPNET was 40%(10/25) and 44%(4/9), respectively. Aberrant methylation of TIG1 in PNET is tumor specific. Loss of or reduced transcript of TIG1 was identified in the majority of PNET cell lines(7/7), which is highly correlated with promoter hypermethylation of the gene. The inverse correlation is supported by the reversed expression of TIG1 in all six cell lines tested after treatment by 5-aza-2′-deoxycytidine. Conclusions TIG1 expression is lost or reduced in the majority of PNET cell lines and the TIG1 gene silencing has close relationship with promoter hypermethylation. Moreover, the frequent aberrant methylation of TIG1 is also observed in primary PNETs, suggesting that TIG1 may play an important role in tumorigenesis of intracranial PNET.